Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Network Comparison Type Value Type Filtered Interaction Map red network_comparison green
Results: HTML CSV LaTeX Showing element 551 to 600 of 3730 in total 
Network Comparison Type: Divided
Value Type: Ranked
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
276\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l32. [source:swissprot;acc:p02433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10716\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.969\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l9. [source:swissprot;acc:p32969]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10741.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08257\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9922.33\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
277\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s29. [source:swissprot;acc:p30054]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.849\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10665\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
267.642\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l17 (l23). [source:swissprot;acc:p18621]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11096.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08245\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10251.6\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
278\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s11. [source:swissprot;acc:p04643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.399\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10642\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
267.088\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
associated molecule with the sh3 domain of stam (amsh) like protein. [source:refseq;acc:nm\_020799]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
11644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08181\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10763.4\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
279\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10614.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08171\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9812.39\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
histone acetyltransferase type b subunit 2 (retinoblastoma binding protein p46) (retinoblastoma-binding protein 7) (rbbp-7). [source:swissprot;acc:q16576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10605\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.42\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
280\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crooked neck-like protein 1 (crooked neck homolog) (hcrn) (cgi-201) (mstp021). [source:swissprot;acc:q9bzj0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10620.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11471.2\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metastasis-associated protein mta1. [source:swissprot;acc:q13330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.512\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10578\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.356\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
281\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l17 (l23). [source:swissprot;acc:p18621]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
241.808\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10557\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
267.335\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 3 (pl scramblase 3) (ca(2+)-dependent phospholipid scramblase 3). [source:swissprot;acc:q9nry6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12522.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0792\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13514.5\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
282\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
252.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10553\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.297\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8095.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07868\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8732.68\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
283\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.828\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
267.346\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
lifeguard; kiaa0950 protein. [source:refseq;acc:nm\_012306]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11107.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11959.2\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
284\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.657\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10541\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.235\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase-related gene segment, exon 5 (fragment). [source:sptrembl;acc:q15677]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
14898.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16041.6\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
285\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj408b20.3 (novel protein similar to 60s acidic ribosomal protein p2 (rplp2)). [source:sptrembl;acc:q9h5a9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9925.58\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.647\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10532\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.242\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
286\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12228.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07573\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11367.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.633\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1052\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
203.251\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
287\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, y isoform 2. [source:swissprot;acc:q8td47]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
240.758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10517\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.079\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17842.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07549\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16590.3\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
288\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s4, x isoform (single copy abundant mrna protein) (scr10). [source:swissprot;acc:p12750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10517\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.078\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
14930.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07517\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16053\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
289\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein g1c (forkhead-related protein fkhl3) (hfk3) (fragment). [source:swissprot;acc:q14488]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
15147.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07489\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14091.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hpaii tiny  fragments locus 9c. [source:refseq;acc:nm\_022727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
272.781\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10486\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
246.892\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
290\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin-1 receptor-associated kinase 4; interleukin-1 receptor associated kinase 4. [source:refseq;acc:nm\_016123]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15147.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07489\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14091.9\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.969\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10428\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
210.064\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
291\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
far upstream element-binding protein; far upstream element binding protein; fuse-binding protein. [source:refseq;acc:nm\_003902]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10922.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11731.8\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear transcription factor y subunit beta (nf-y protein chain b) (nf-yb) (ccaat-binding transcription factor subunit a) (cbf-a) (caat- box dna binding protein subunit b). [source:swissprot;acc:p25208]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.679\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
228.037\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
292\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15a. [source:swissprot;acc:p39027]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
241.411\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.414\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10280.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07368\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9574.98\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
293\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l23 (l17). [source:swissprot;acc:p23131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
265.717\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ran-binding protein 2-like 1 isoform 2; sperm membrane protein bs-63; ran-binding protein 2-like 1. [source:refseq;acc:nm\_032260]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10287.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07344\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
9583.27\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
294\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca2 and cdkn1a-interacting protein isoform bccipalpha; brca2 and cdkn1a-interacting protein; cdk inhibitor p21 binding protein; bccipalpha; bccipbeta; tok-1alpha; tok-1beta. [source:refseq;acc:nm\_016567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
240.782\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
265.717\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 20/15 kda subunits (tafii- 20/tafii-15) (tafii20/tafii15). [source:swissprot;acc:q16514]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13981.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07343\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13025.1\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
295\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.273\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.103\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
202.423\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
13687.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07339\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12751.8\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
296\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lon protease homolog, mitochondrial precursor (ec 3.4.21.-) (lon protease-like protein) (lonp) (lonhs). [source:swissprot;acc:p36776]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
10194.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07335\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10941.8\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l4 isoform a. [source:refseq;acc:nm\_015956]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
241.282\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10294\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
266.12\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
297\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l7. [source:swissprot;acc:p18124]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
235.727\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1029\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
259.984\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8123.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07327\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8719\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
298\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein sa (p40) (34/67 kda laminin receptor) (colon carcinoma laminin-binding protein) (nem/1chd4) (multidrug resistance- associated protein mgr1-ag). [source:swissprot;acc:p08865]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
11977.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07219\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12842.5\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
calpain 2, large [catalytic] subunit precursor (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (m-type) (m-calpain) (millimolar-calpain) (calpain large polypeptide l2). [source:swissprot;acc:p17655]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
268.632\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10281\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
243.588\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
299\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3 beta-hydroxysteroid dehydrogenase (fragments). [source:sptrembl;acc:q9udk8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12338.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07178\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11512.3\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
calpain 1, large [catalytic] subunit (ec 3.4.22.17) (calcium-activated neutral proteinase) (canp) (mu-type) (mucanp) (micromolar-calpain). [source:swissprot;acc:p07384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
268.635\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10281\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
243.592\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
300\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9270.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0717\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8650.24\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
150.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10196\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
166.351\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/